CTHRC1

Across TCGA pan-cancer cohorts, CTHRC1 mass-spec protein differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of CTHRC1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where CTHRC1 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CTHRC1 is over-expressed in tumor.

COAD, CCRCC, and HNSC are the cancer types where CTHRC1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CTHRC1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	IV	+2.019	<.001	12	view →
CCRCC	Female	II,III,IV	+1.751	<.001	12	view →
HNSC	All	IV	+1.872	<.001	11	view →
LUAD	Male	III,IV	+1.794	<.001	9	view →
LSCC	Male	All	+1.761	<.001	9	view →
PDAC	Male	All	+1.355	<.001	7	view →
OV	All	All	+1.120	.022	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

CTHRC1–COAD

Open the COAD breakdown →